Exane Derivatives’s Macy's M Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $12.9K | Sell |
707
-1,400
| -66% | -$31.7K | 0.01% | 382 |
|
|
2022
Q1 | $51.3K | Hold |
2,107
| – | – | 0.01% | 565 |
|
|
2021
Q4 | $55.2K | Buy |
2,107
+1,347
| +177% | +$36.7K | 0.01% | 484 |
|
|
2021
Q3 | $17.2K | Sell |
760
-10,495
| -93% | -$210K | ﹤0.01% | 693 |
|
|
2021
Q2 | $209K | Sell |
11,255
-8,608
| -43% | -$153K | 0.05% | 380 |
|
|
2021
Q1 | $322K | Sell |
19,863
-15,856
| -44% | -$242K | 0.09% | 207 |
|
|
2020
Q4 | $402K | Sell |
35,719
-29,441
| -45% | -$252K | 0.12% | 197 |
|
|
2020
Q3 | $371K | Sell |
65,160
-1,955
| -3% | -$13K | 0.11% | 162 |
|
|
2020
Q2 | $462K | Sell |
67,115
-17,935
| -21% | -$110K | 0.12% | 144 |
|
|
2020
Q1 | $418K | Buy |
85,050
+37,367
| +78% | +$507K | 0.12% | 137 |
|
|
2019
Q4 | $830K | Buy |
+47,683
| New | +$746K | 0.15% | 111 |
|
|
2019
Q3 | – | Sell |
-127,588
| Closed | -$2.74M | – | 678 |
|
|
2019
Q2 | $2.74M | Buy |
127,588
+104,524
| +453% | +$2.38M | 0.48% | 64 |
|
|
2019
Q1 | $554K | Sell |
23,064
-8,829
| -28% | -$223K | 0.11% | 147 |
|
|
2018
Q4 | $950K | Buy |
+31,893
| New | +$1.05M | 0.17% | 124 |
|
|
2018
Q3 | – | Sell |
-67,243
| Closed | -$2.52M | – | 717 |
|
|
2018
Q2 | $2.52M | Sell |
67,243
-22,641
| -25% | -$759K | 0.42% | 45 |
|
|
2018
Q1 | $2.61M | Buy |
89,884
+42,229
| +89% | +$1.14M | 0.52% | 41 |
|
|
2017
Q4 | $1.2M | Buy |
47,655
+14,505
| +44% | +$318K | 0.21% | 89 |
|
|
2017
Q3 | $723K | Sell |
33,150
-4,589
| -12% | -$101K | 0.14% | 104 |
|
|
2017
Q2 | $877K | Sell |
37,739
-7,513
| -17% | -$192K | 0.19% | 98 |
|
|
2017
Q1 | $1.34M | Buy |
45,252
+17,451
| +63% | +$539K | 0.3% | 80 |
|
|
2016
Q4 | $995K | Sell |
27,801
-1,344
| -5% | -$52.3K | 0.2% | 89 |
|
|
2016
Q3 | $1.08M | Sell |
29,145
-2,272
| -7% | -$82.3K | 0.16% | 91 |
|
|
2016
Q2 | $1.06M | Buy |
31,417
+20,962
| +200% | +$751K | 0.17% | 84 |
|
|
2016
Q1 | $461K | Sell |
10,455
-6,878
| -40% | -$284K | 0.06% | 138 |
|
|
2015
Q4 | $606K | Buy |
17,333
+16,421
| +1,801% | +$712K | 0.08% | 104 |
|
|
2015
Q3 | $46.8K | Buy |
912
+201
| +28% | +$12.6K | 0.01% | 274 |
|
|
2015
Q2 | $48K | Sell |
711
-540
| -43% | -$36.5K | 0.01% | 291 |
|
|
2015
Q1 | $81.2K | Sell |
1,251
-599
| -32% | -$38.5K | 0.01% | 284 |
|
|
2014
Q4 | $122K | Buy |
+1,850
| New | +$112K | 0.02% | 265 |
|
Other funds holding M
AL
Exane Derivatives's M Position: Q2 2022 in Review
Exane Derivatives reduced its Macy's (M) stake by 66% in Q2 2022, selling an estimated $31.7K and leaving 707 shares worth $12.9K. The position accounts for 0.01% of the portfolio, ranked #382.
Exane Derivatives first reported a position in M in Q4 2014 and has held it in 29 quarters since. The position peaked at $2.74M in Q2 2019. 416 funds tracked by Wall St. Rank hold M as of Q2 2022.
- Exane Derivatives held 707 shares of Macy's worth $12.9K as of Q2 2022.
- Exane Derivatives sold 1,400 Macy's shares in Q2 2022, an estimated $31.7K.
- Macy's made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #382 holding.
- Exane Derivatives first reported a position in Macy's in Q4 2014 and has held it in 29 quarters since.
- Exane Derivatives's Macy's position peaked at $2.74M in Q2 2019.
- 416 funds tracked by Wall St. Rank held Macy's as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.